Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents

Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents

US Patent 9938316 · Granted Apr 10, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereo2021
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereo2021
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereo2021
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereo2021
(Bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorde2021
System, method, and computer program for metadata driven interface orchestration2020
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereo2020
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereo2020
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereo2020
Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereo2020
Hyper-osmotic eye contact lens2018
(Bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorde2016